National Center of Neurology and Psychiatry;Nippon Shinyaku Co., Ltd.
发明人:
申请号:
EP19182708.8
公开号:
EP3594347A1
申请日:
2012.12.27
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention provides a pharmaceutical agent which causes skipping of the 55th exon in the human dystrophin gene with a high efficiency.The present invention provides an oligomer which efficiently enables to cause skipping of the 55th exon in the human dystrophin gene.